Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1978 Oct;188(4):481–492. doi: 10.1097/00000658-197810000-00006

Use of CEA as an Indicator of Early Recurrence and as a Guide to a Selected Second-look Procedure in Patients with Colorectal Cancer

Harold J Wanebo, Maus Stearns, Morton K Schwartz
PMCID: PMC1396853  PMID: 697433

Abstract

The usefulness of the CEA as an indicator of recurrence and a guide to selected second-look surgery was evaluated from a retrospective analysis of 358 patients with colorectal cancer and from a prospective experience with 16 patients all of whom had been admitted for second-look surgery because of postoperative elevations of CEA only. Our previous experience had shown that after curative resection the CEA usually returned to normal levels (less than 5 ng/ml) within one month, but became elevated at time of clinically obvious recurrence being very high in patients with liver metastases, but only moderately elevated or normal in patients with local recurrence. All 16 patients had previously had curative resection of colorectal cancer; 13 in the rectum or rectosigmoid and three in the right colon. There were 13 Dukes' C and three Dukes' B cancers. All had been followed clinically and by CEA testing at three monthly intervals and were considered free of disease (NED) at time of CEA elevation.

The median disease free interval was 13 months (range 4-57 months) and the median CEA prompting admission for second-look operation was 21 ng/ml (range 10-56 ng/ml). The sites of recurrence were liver in six, lung in two and localized disease in six. Two patients had negative exploration for recurrence and were found to have cholelithiasis only (one of these later died of metastases). Resection for cure was done in seven and palliative resection or biopsy only was done in nine patients. At this time, four patients are NED (12-37 months), five are living with disease (10-16 months) and seven have died of disease (2-12 months). The CEA test provides a method of early detection of recurrence and may permit surgical retrieval in selected patients and earlier initiation of palliation in other patients. The longterm effects in patient salvage remain to be defined.

Full text

PDF
481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTLER V. B., COLLER F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954 Jun;139(6):846–852. doi: 10.1097/00000658-195406000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexander J. C., Silverman N. A., Chretien P. B. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA. 1976 May 3;235(18):1975–1979. [PubMed] [Google Scholar]
  3. Bivins B. A., Meeker W. R., Jr, Griffen W. O., Jr, Pellegrini J., Parker J. C., Jr Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer. J Surg Res. 1975 Mar;18(3):257–261. doi: 10.1016/0022-4804(75)90149-3. [DOI] [PubMed] [Google Scholar]
  4. Cass A. W., Million R. R., Pfaff W. W. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer. 1976 Jun;37(6):2861–2865. doi: 10.1002/1097-0142(197606)37:6<2861::aid-cncr2820370643>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  5. DUKES C. E., BUSSEY H. J. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958 Sep;12(3):309–320. doi: 10.1038/bjc.1958.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gunderson L. L., Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer. 1974 Oct;34(4):1278–1292. doi: 10.1002/1097-0142(197410)34:4<1278::aid-cncr2820340440>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  9. Hansen H. J., Snyder J. J., Miller E., Vandevoorde J. P., Miller O. N., Hines L. R., Burns J. J. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol. 1974 Mar;5(2):139–147. doi: 10.1016/s0046-8177(74)80061-4. [DOI] [PubMed] [Google Scholar]
  10. Holyoke D., Reynoso G., Chu T. M. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Ann Surg. 1972 Oct;176(4):559–564. doi: 10.1097/00000658-197217640-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Holyoke E. D., Cooper E. H. CEA and tumor markers. Semin Oncol. 1976 Dec;3(4):377–385. [PubMed] [Google Scholar]
  12. Khoo S. K., Mackay I. R. Carcinoembryonic antigen in serum in diseases of the liver and pancreas. J Clin Pathol. 1973 Jul;26(7):470–475. doi: 10.1136/jcp.26.7.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Laurence D. J., Neville A. M. Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer. 1972 Oct;26(5):335–355. doi: 10.1038/bjc.1972.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lo Gerfo P., Krupey J., Hansen H. J. Demonstration of an antigen common to several varieties of neoplasia. N Engl J Med. 1971 Jul 15;285(3):138–141. doi: 10.1056/NEJM197107152850302. [DOI] [PubMed] [Google Scholar]
  15. Lo Gerfo P., Lo Gerfo F., Herter F., Barker H. G., Hansen H. J. Tumor-associated antigen in patients with carcinoma of the colon. Am J Surg. 1972 Feb;123(2):127–131. doi: 10.1016/0002-9610(72)90321-2. [DOI] [PubMed] [Google Scholar]
  16. Mach J. P., Jaeger P., Bertholet M. M., Ruegsegger C. H., Loosli R. M., Pettavel J. Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet. 1974 Sep 7;2(7880):535–540. doi: 10.1016/s0140-6736(74)91872-8. [DOI] [PubMed] [Google Scholar]
  17. Mackay A. M., Patel S., Carter S., Stevens U., Laurence D. J., Cooper E. H., Neville A. M. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J. 1974 Nov 16;4(5941):382–385. doi: 10.1136/bmj.4.5941.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Martin E. W., Jr, James K. K., Hurtubise P. E., Catalano P., Minton J. P. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures. Cancer. 1977 Feb;39(2):440–446. doi: 10.1002/1097-0142(197702)39:2<440::aid-cncr2820390212>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  19. Moertel C. G., Schutt A. J., Go V. L. Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA. 1978 Mar 13;239(11):1065–1066. [PubMed] [Google Scholar]
  20. Moore T. L., Kantrowitz P. A., Zamcheck N. Carcinoembryonic antigen (CEA) in inflammatory bowel disease. JAMA. 1972 Nov 20;222(8):944–947. [PubMed] [Google Scholar]
  21. Moore T. L., Kupchik H. Z., Marcon N., Zamcheck N. Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders. Am J Dig Dis. 1971 Jan;16(1):1–7. doi: 10.1007/BF02233781. [DOI] [PubMed] [Google Scholar]
  22. Neville A. M., Cooper E. H. Biochemical monitoring of cancer. A review. Ann Clin Biochem. 1976 Jan;13(1):283–305. doi: 10.1177/000456327601300101. [DOI] [PubMed] [Google Scholar]
  23. Reynoso G., Chu T. M., Guinan P., Murphy G. P. Carcinoembryonic antigen in patients with tumors of the urogenital tract. Cancer. 1972 Jul;30(1):1–4. doi: 10.1002/1097-0142(197207)30:1<1::aid-cncr2820300102>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  24. Reynoso G., Chu T. M., Holyoke D., Cohen E., Nemoto T., Wang J. J., Chuang J., Guinan P., Murphy G. P. Carcinoembryonic antigen in patients with different cancers. JAMA. 1972 Apr 17;220(3):361–365. [PubMed] [Google Scholar]
  25. Rule A. H., Goleski-Reilly C., Sachar D. B., Vandevoorde J., Janowitz H. D. Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut. 1973 Nov;14(11):880–884. doi: 10.1136/gut.14.11.880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stevens D. P., Mackay I. R. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet. 1973 Dec 1;2(7840):1238–1239. doi: 10.1016/s0140-6736(73)90975-6. [DOI] [PubMed] [Google Scholar]
  27. Sugarbaker P. H., Zamcheck N., Moore F. D. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer. Cancer. 1976 Dec;38(6):2310–2315. doi: 10.1002/1097-0142(197612)38:6<2310::aid-cncr2820380618>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  28. Turnbull R. B., Jr, Kyle K., Watson F. R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. doi: 10.1097/00000658-196709000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vincent R. G., Chu T. M. Carcinoembryonic antigen in patients with carcinoma of the lung. J Thorac Cardiovasc Surg. 1973 Aug;66(2):320–328. [PubMed] [Google Scholar]
  30. WANGENSTEEN O. H., LEWIS F. J., TONGEN L. A. The "second-look" in cancer surgery; a patient with colic cancer and involved lymph nodes negative on the "sixth-look". J Lancet. 1951 Aug;71(8):303–307. [PubMed] [Google Scholar]
  31. Walz B. J., Lindstrom E. R., Butcher H. R., Jr, Baglan R. J. Natural history of patients after abdominal-perineal resection. Implications for radiation therapy. Cancer. 1977 Jun;39(6):2437–2442. doi: 10.1002/1097-0142(197706)39:6<2437::aid-cncr2820390621>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES